0001169245-22-000075.txt : 20220524
0001169245-22-000075.hdr.sgml : 20220524
20220524171306
ACCESSION NUMBER: 0001169245-22-000075
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220520
FILED AS OF DATE: 20220524
DATE AS OF CHANGE: 20220524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Birchall Jonathan
CENTRAL INDEX KEY: 0001892776
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38697
FILM NUMBER: 22958017
MAIL ADDRESS:
STREET 1: C/O PHASEBIO PHARMACEUTICALS, INC.
STREET 2: 1 GREAT VALLEY PARKWAY, SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001169245
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 030375697
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY
STREET 2: SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (610) 981-6500
MAIL ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY
STREET 2: SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: Phase Biosciences Inc
DATE OF NAME CHANGE: 20061013
FORMER COMPANY:
FORMER CONFORMED NAME: DT BIOSCIENCES INC
DATE OF NAME CHANGE: 20020315
4
1
wf-form4_165342676547850.xml
FORM 4
X0306
4
2022-05-20
0
0001169245
PhaseBio Pharmaceuticals Inc
PHAS
0001892776
Birchall Jonathan
C/O PHASEBIO PHARMACEUTICALS, INC.
1 GREAT VALLEY PARKWAY, SUITE 30
MALVERN
PA
19355
0
1
0
0
Chief Commercial Officer
Common Stock
2022-05-20
4
A
0
20000
0.6813
A
20000
D
Shares were acquired under the Issuer's Employee Stock Purchase Plan ("ESPP") in a transaction that is exempt under both Rule 16b-3(c) and Rule 16b-3(d).
In accordance with the ESPP provisions, these shares were purchased based on 85% of the closing price of the Issuer's common stock on May 20, 2022.
/s/ John P. Sharp, Attorney-in-fact
2022-05-24